Cerebrovascular Function in Sporadic and Genetic Cerebral Small Vessel Disease
Annals of Neurology · 2025
DOI: 10.1002/ana.27136 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Annals of Neurology, 2025. Verfasst von Michael S Stringer und 24 weiteren Autor:innen. Beteiligte Einrichtung: Brain Research Imaging Center, Center for Clinical Brain Sciences, UK Dementia Institute Center at the University of Edinburgh, Edinburgh, UK. Hauptthemen laut MEDLINE: Cerebral Small Vessel Diseases, CADASIL, Cerebrovascular Circulation. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Chief Scientist Office, Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Objective
Cerebral small vessel diseases (SVDs) are associated with cerebrovascular dysfunction, such as increased blood–brain barrier leakage (permeability surface area product), vascular pulsatility, and decreased cerebrovascular reactivity (CVR). No studies assessed all 3 functions concurrently. We assessed 3 key vascular functions in sporadic and genetic SVD to determine associations with SVD severity, subtype, and interrelations.
Methods
In this prospective, cross‐sectional, multicenter INVESTIGATE‐SVDs study, we acquired brain magnetic resonance imaging in patients with sporadic SVD/cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), including structural, quantitative microstructural, permeability surface area product, blood plasma volume fraction, vascular pulsatility, and CVR (in response to CO 2 ) scans. We determined vascular function and white matter hyperintensity (WMH) associations, using covariate‐adjusted linear regression; normal‐appearing white matter and WMH differences, interrelationships between vascular functions, using linear mixed models; and major sources of variance using principal component analyses.
Results
We recruited 77 patients (45 sporadic/32 CADASIL) at 3 sites. In adjusted analyses, patients with worse WMH had lower CVR ( B = −1.78, 95% CI −3.30, −0.27) and blood plasma volume fraction ( B = −0.594, 95% CI −0.987, −0.202). CVR was worse in WMH than normal‐appearing white matter (eg, CVR: B = −0.048, 95% CI −0.079, −0.017). Adjusting for WMH severity, SVD subtype had minimal influence on vascular function (eg, CVR in CADASIL vs sporadic: B = 0.0169, 95% CI −0.0247, 0.0584). Different vascular function mechanisms were not generally interrelated (eg, permeability surface area product~CVR: B = −0.85, 95% CI −4.72, 3.02). Principal component analyses identified WMH volume/quantitative microstructural metrics explained most variance in CADASIL and arterial pulsatility in sporadic SVD, but similar main variance sources.
Interpretation
Vascular function was worse with higher WMH, and in WMH than normal‐appearing white matter. Sporadic SVD‐CADASIL differences largely reflect disease severity. Limited vascular function interrelations may suggest disease stage‐specific differences. ANN NEUROL 2025;97:483–498
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Brain Research Imaging Center, Center for Clinical Brain Sciences, UK Dementia Institute Center at the University of Edinburgh, Edinburgh, UK.
- Institute for Stroke and Dementia Research (ISD), University Hospital, Munich, Germany.
- Department of Neurology, CARIM School for cardiovascular diseases, Maastricht University Medical Center, Maastricht, the Netherlands.
- Medical Image Analysis Center (MIAC AG) and Department of Biomedical Engineering, University of Basel, Basel, Switzerland.
- Department of Radiology, University Hospital, Munich, Germany.
- Department of Radiology & Nuclear Medicine, Maastricht University Medical Center, Schools for Mental Health & Neuroscience and Cardiovascular Disease, Maastricht, the Netherlands.
ORCID-Profile: Michael S Stringer, Walter H Backes, Joanna M Wardlaw
Förderung
- Wellcome Trust
- Chief Scientist Office
- Deutsche Forschungsgemeinschaft
- Scottish Funding Council through the SINAPSE collaboration
- Biotechnology and Biological Sciences Research Council
- Fondation Leducq
- Stroke Association Postdoctoral Fellowship, Garfield Weston Foundation Senior Clinical Lecture, Princess Margaret Research Development Fellowship
- Edinburgh and Lothians Health Foundation
Zitieren
APA
Stringer, M. S., Blair, G. W., Kopczak, A., Kerkhofs, D., Thrippleton, M. J., Chappell, F. M., Maniega, S. M., Brown, R., Shuler, K., Hamilton, I., Garcia, D. J., Doubal, F. N., Clancy, U., Sakka, E., Poliakova, T., Janssen, E., Duering, M., Ingrisch, M., Staals, J., …, & SVDs@target consortium (2025). Cerebrovascular Function in Sporadic and Genetic Cerebral Small Vessel Disease. Annals of Neurology. https://doi.org/10.1002/ana.27136
Vancouver
Stringer MS, Blair GW, Kopczak A, Kerkhofs D, Thrippleton MJ, Chappell FM, et al. Cerebrovascular Function in Sporadic and Genetic Cerebral Small Vessel Disease. Annals of Neurology. 2025. doi:10.1002/ana.27136
BibTeX
@article{Stringer2025,
author = {Stringer, Michael S and Blair, Gordon W and Kopczak, Anna and Kerkhofs, Danielle and Thrippleton, Michael J and Chappell, Francesca M and Maniega, Susana Muñoz and Brown, Rosalind and Shuler, Kirsten and Hamilton, Iona and Garcia, Daniela Jaime and Doubal, Fergus N and Clancy, Una and Sakka, Eleni and Poliakova, Tetiana and Janssen, Esther and Duering, Marco and Ingrisch, Michael and Staals, Julie and Backes, Walter H and van Oostenbrugge, Robert and Biessels, Geert Jan and Dichgans, Martin and Wardlaw, Joanna M and SVDs@target consortium, SVDs@target consortium},
title = {Cerebrovascular Function in Sporadic and Genetic Cerebral Small Vessel Disease},
journal = {Annals of Neurology},
year = {2025},
doi = {10.1002/ana.27136}
}
EUVIMED